Health

Taylor Swift’s new album, “The Tortured Poets Department,” has sparked discussions among healthcare professionals on social media platforms. Medical student @NDAcademic pointed out the relatability of lyrics like “I love you, it’s ruining my life,” shedding light on the emotional toll of working in healthcare settings. Luxury Scrubs and Adventure Hats: Are They Necessary? The
0 Comments
A recent study conducted by Chinese researchers introduced an innovative strategy involving sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical hematopoietic stem-cell transplantation (HSCT) for patients with relapsed or refractory hematologic cancers. This groundbreaking approach, which eliminates the need for graft-versus-host disease (GVHD) prophylaxis, has shown promising results in terms of complete
0 Comments
The recent news of Dr. Marsha Certain, an interventional cardiologist from Georgia, being killed in an apparent murder-suicide at the age of 69 is truly devastating. The loss of a healthcare provider, especially in the midst of a global health crisis, is a stark reminder of the fragility of life. The release of 239 genetic
0 Comments
The realm of medical news publications is not without its fair share of controversy. Recently, the New England Journal of Medicine came under fire for cutting off certain publications from advanced access to its embargoed journal articles. This decision was met with criticism from experts like Ivan Oransky, MD, who likened it to a ‘don’t
0 Comments
The New England Journal of Medicine (NEJM) recently announced a significant change in its access policy regarding embargoed journal articles. According to Dawn Peters, director of strategic communications & media relations at NEJM Group, news outlets targeting physician readers will no longer qualify for embargoed access. This decision has implications for reporters who apply to
0 Comments
A recent phase IIb PARADIGM trial has shown promising results for a novel treatment candidate for amyotrophic lateral sclerosis (ALS). The treatment, known as PrimeC, is a combination of two FDA-approved drugs, ciprofloxacin, and celecoxib. The trial, presented at the American Academy of Neurology annual meeting by Merit Cudkowicz, MD, MSc, of Massachusetts General Hospital,
0 Comments
Antipsychotic drugs are commonly prescribed to patients with dementia to manage behavioral and psychological symptoms. However, a recent population-based matched cohort study from the U.K. has shed light on the increased risk of adverse outcomes associated with the use of antipsychotics in dementia patients. The study analyzed data from over 170,000 adults with dementia and
0 Comments
Duchenne muscular dystrophy (DMD) is a devastating genetic disorder primarily affecting boys, characterized by mutations in the dystrophin gene leading to muscle damage and weakness. Recently, Viltolarsen, also known as Viltepso, has shown promise as a potential treatment for DMD through exon-skipping therapy. The open-label, phase II Galactic53 trial revealed intriguing results regarding the safety
0 Comments